MedTrace Logo

Nexium RESPONSE Trial

NCT00318968 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 1000

Last updated 2009-01-26

No results posted yet for this study

Summary

The primary purpose of the study is to develop, and test, an algorithm for identification of responders to empirical esomeprazole treatment in general practices.

Conditions

  • GERD

Interventions

DRUG

Esomeprazole

Sponsors & Collaborators

Principal Investigators

  • Villy Meineche Schmidt, MD · Charlottenlund Research Site

  • Stig Waldorff, MD · AstraZeneca, Denmark

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-05-31
Completion
2007-11-30

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00318968 on ClinicalTrials.gov